NO164771C - Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.

Info

Publication number
NO164771C
NO164771C NO844778A NO844778A NO164771C NO 164771 C NO164771 C NO 164771C NO 844778 A NO844778 A NO 844778A NO 844778 A NO844778 A NO 844778A NO 164771 C NO164771 C NO 164771C
Authority
NO
Norway
Prior art keywords
carbon atoms
alkyl
pyrid
substituted
nitrogen atom
Prior art date
Application number
NO844778A
Other languages
English (en)
Other versions
NO844778L (no
NO164771B (no
Inventor
Albrecht Franke
Wolfgang Spiegler
Hardo Siegel
Claus D Mueller
Gerda Von Philipsborn
Dieter Lenke
Josef Gries
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO844778L publication Critical patent/NO844778L/no
Publication of NO164771B publication Critical patent/NO164771B/no
Publication of NO164771C publication Critical patent/NO164771C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Machine Translation (AREA)
NO844778A 1983-12-02 1984-11-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater. NO164771C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833343671 DE3343671A1 (de) 1983-12-02 1983-12-02 Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Publications (3)

Publication Number Publication Date
NO844778L NO844778L (no) 1985-06-03
NO164771B NO164771B (no) 1990-08-06
NO164771C true NO164771C (no) 1990-11-14

Family

ID=6215907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844778A NO164771C (no) 1983-12-02 1984-11-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.

Country Status (14)

Country Link
US (1) US5118685A (no)
EP (1) EP0152556B1 (no)
JP (1) JPS60136557A (no)
AT (1) ATE25083T1 (no)
CA (1) CA1233465A (no)
CS (1) CS251090B2 (no)
DE (2) DE3343671A1 (no)
DK (1) DK158979C (no)
ES (1) ES538161A0 (no)
FI (1) FI86174C (no)
HU (1) HU192625B (no)
IL (1) IL73702A (no)
NO (1) NO164771C (no)
ZA (1) ZA849380B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853408A (en) * 1985-04-23 1989-08-01 Roussel Uclaf 4-phenylpropyl-indoles having antiarythmic activity
FR2584070B1 (fr) * 1985-06-27 1987-08-28 Roussel Uclaf Nouveaux derives de l'hydroxy alkoxy 4-phenyl propyl indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant.
FR2624858B1 (fr) * 1987-12-21 1990-06-01 Esteve Labor Dr Nouveaux derives de 2-propanol, leur preparation et leur application en tant que medicaments
DE3825561A1 (de) * 1988-07-28 1990-02-01 Basf Ag P-hydroxiphenon-derivate und diese enthaltende arzneimittel
AT401726B (de) * 1993-05-17 1996-11-25 Gerhard Dr Ecker O-acylaryloxypropanolamine mit tertiärem oder quartärem stickstoff als reversionsmodulatoren für p-glykoprotein mediierte multidrug-resistenz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives
DE2001431C3 (de) * 1970-01-06 1974-12-12 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben
GB1560006A (en) * 1977-08-18 1980-01-30 Laroche Navarron Sa Benzoyl furan derivatives process for their preparation and therapeutic applications thereof
DE2835438A1 (de) * 1978-08-12 1980-03-06 Basf Ag Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
DE3133814C2 (de) * 1981-08-25 1983-12-22 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenon, seine Säureadditionssalze und Arzneimittel
DE3226863A1 (de) * 1981-09-18 1983-04-07 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
FI86174B (fi) 1992-04-15
JPS60136557A (ja) 1985-07-20
ZA849380B (en) 1985-08-28
DK158979B (da) 1990-08-13
ES8601136A1 (es) 1985-11-01
DK566684D0 (da) 1984-11-29
EP0152556B1 (de) 1987-01-21
NO844778L (no) 1985-06-03
CA1233465A (en) 1988-03-01
DE3462136D1 (en) 1987-02-26
IL73702A (en) 1988-03-31
CS251090B2 (en) 1987-06-11
ES538161A0 (es) 1985-11-01
HU192625B (en) 1987-06-29
DK158979C (da) 1991-01-07
DK566684A (da) 1985-06-03
FI844729A0 (fi) 1984-11-30
HUT36802A (en) 1985-10-28
FI86174C (fi) 1992-07-27
EP0152556A1 (de) 1985-08-28
US5118685A (en) 1992-06-02
IL73702A0 (en) 1985-03-31
ATE25083T1 (de) 1987-02-15
JPH0552305B2 (no) 1993-08-05
DE3343671A1 (de) 1985-06-20
FI844729L (fi) 1985-06-03
NO164771B (no) 1990-08-06

Similar Documents

Publication Publication Date Title
ES8102107A1 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
SE7512477L (sv) Forfarande for framstellning av heterocykliska foreningar
ES2001936A6 (es) Procedimiento para la preparacion de indoles sustituidos con heterociclos.
IE43731L (en) Triazolyl and imidazolyl derivatives
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
GB2023133A (en) Heterocyclic derivatives
DE2967513D1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions containing them
ES463803A1 (es) Procedimiento para la produccion de hidroxilaminas o-alqui- ladas.
KR880006196A (ko) 알레르기 및 염증 치료제인 디하이드로피리딘
ES414289A1 (es) Procedimiento de preparacion de derivados de la a-1-pirro- lina.
NO164771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
GB1424450A (en) Isoindoline intermediates
ES486071A1 (es) Un procedimiento para la preparacion de derivados de amina
ES8107198A1 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
GB1185934A (en) Derivatives of 1,3(2H,4H)-Dioxoisoquinoline and preparation thereof
NO853329L (no) Fremgangsmaate ved fremstilling av 1,6-nafthyridinderivater.
ES8101071A1 (es) Procedimiento para preparar nuevos derivados de (piridil-2)-2-tetrahidrotiofeno
FR2479219B1 (no)
GB2015524A (en) Pyridine derivatives
ES2058182T3 (es) Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas.
GB1511413A (en) Phosphoryloxy-thiophene compounds processes for preparing them and pesticidal compositions incorporating them
ES454285A1 (es) Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina.
GB1113783A (en) Improvements in or relating to esters of 4-alkyl-2,6-dinitrophenols and pesticides containing them
ES419266A1 (es) Un procedimiento para preparar derivados de quinazolina.